Assessing Cognitive Performance Among Adults With Attention Disorders Working on Treadmill

• Status: Recruiting
• Trial end date: 2022-10-01
• Target enrollment: 0
• Participant gender: All

Summary

Randomized clinical trial in which individuals who have been diagnosed with ADHD and are regularly treated with Methylphenidate will be test for cognitive performance and will be randomly examined in the following four conditions:

• While taking Methylphenidate and sitting at a desk

• While taking Methylphenidate and walking on a treadmill workstation

• Without taking Methylphenidate while sitting at a desk

• Without taking Methylphenidate while walking on a treadmill workstation The investigators will compare the cognitive achievements outcomes and evaluate the efficiency of studying in each of these four conditions.

• Phase: Phase 2/Phase 3
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Ariel University
• Collaborator: Maccabi Healthcare Services, Israel
• Treatments: Methylphenidate

Criteria

Inclusion Criteria:

• Insured by Maccabi Health Services

• Diagnosed with ADHD by Neurologist/Psychiatrist/Developmental Doctor

• Take Methylphenidate as part of the treatment for ADHD AND have agreed to not take the drug if asked to

• Understand the language and simple instruction

• Willing to participate in the study and sign the agreement form

Exclusion Criteria:

• Suffer from heart disease or chronic respiratory illness

• Women who are pregnant